Jane Street’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-941,067
| Closed | -$8.5M | – | 13126 |
|
|
2025
Q4 | $8.5M | Buy |
941,067
+555,963
| +144% | +$4.15M | ﹤0.01% | 2523 |
|
|
2025
Q3 | $1.2M | Sell |
385,104
-15,493
| -4% | -$41K | ﹤0.01% | 5917 |
|
|
2025
Q2 | $857K | Buy |
400,597
+351,962
| +724% | +$568K | ﹤0.01% | 5904 |
|
|
2025
Q1 | $55.9K | Buy |
+48,635
| New | +$83.5K | ﹤0.01% | 8974 |
|
|
2024
Q4 | – | Sell |
-42,272
| Closed | -$92.2K | – | 10715 |
|
|
2024
Q3 | $92.2K | Sell |
42,272
-103,504
| -71% | -$238K | ﹤0.01% | 9021 |
|
|
2024
Q2 | $337K | Buy |
145,776
+24,178
| +20% | +$100K | ﹤0.01% | 7628 |
|
|
2024
Q1 | $669K | Sell |
121,598
-340,551
| -74% | -$1.56M | ﹤0.01% | 6152 |
|
|
2023
Q4 | $1.14M | Buy |
462,149
+446,782
| +2,907% | +$4.24M | ﹤0.01% | 5325 |
|
|
2023
Q3 | $534K | Sell |
15,367
-36,280
| -70% | -$1.25M | ﹤0.01% | 6200 |
|
|
2023
Q2 | $1.69M | Buy |
51,647
+27,051
| +110% | +$932K | ﹤0.01% | 4407 |
|
|
2023
Q1 | $824K | Buy |
+24,596
| New | +$956K | ﹤0.01% | 5382 |
|
|
2022
Q4 | – | Sell |
-11,123
| Closed | -$388K | – | 10245 |
|
|
2022
Q3 | $388K | Buy |
+11,123
| New | +$246K | ﹤0.01% | 7156 |
|
Other funds holding VTYX
Jane Street's VTYX Position: Q1 2026 in Review
Jane Street sold out of Ventyx Biosciences (VTYX) in Q1 2026, closing a stake of 941,067 shares — an estimated $8.5M sold.
Jane Street first reported a position in VTYX in Q3 2022 and held it in 12 quarters. The position peaked at $8.5M in Q4 2025. 1 fund tracked by Wall St. Rank holds VTYX as of Q1 2026.
- Jane Street reported no remaining Ventyx Biosciences position as of Q1 2026 after selling out during the quarter.
- Jane Street sold 941,067 Ventyx Biosciences shares in Q1 2026, an estimated $8.5M.
- Jane Street first reported a position in Ventyx Biosciences in Q3 2022 and held it in 12 quarters.
- Jane Street's Ventyx Biosciences position peaked at $8.5M in Q4 2025.
- 1 fund tracked by Wall St. Rank held Ventyx Biosciences as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.